DELAINE SMITH: Open Payments
NPI 1073589073 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,411 in 75 payments from 12 companies in 2025. Trend: 2023 $1,158 · 2024 $1,133 · 2025 $1,411
Food & beverage: $1,411
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $289 |
| E.R. Squibb & Sons, L.L.C. | 15 | $224 |
| Vanda Pharmaceuticals Inc. | 8 | $215 |
| Lundbeck LLC | 8 | $177 |
| Teva Pharmaceuticals USA, Inc. | 13 | $148 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $129 |
| Alkermes, Inc. | 4 | $94 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| Shockwave Medical, Inc | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
Products named: REXULTI, HETLIOZ, ABILIFY MAINTENA, CAPLYTA, COBENFY, AUSTEDO XR, ARISTADA, INGREZZA.
Industry payments across KS — which companies pay providers there.
